Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in ...
SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long ...
Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback